A triple-drug therapy for pancreatic cancer has shown promise in early animal tests, pointing to a potential new treatment for a disease with a notoriously low survival rate. Considered one of the ...

Share on Pinterest Could an experimental drug trio fight difficult-to-treat pancreatic cancer? Experiments in mouse models show promise. Image credit: adamkaz/Getty Images Pancreatic ductal ...

Scientists say they have found a pattern of so-called epigenetic 'marks' in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may keep at least a ...

Mutations in the KRAS gene are the major driver of pancreatic cancer. The resulting protein controls multiple signaling pathways involved in cell growth and survival. In cancer, the gene is mutated to ...

SAN DIEGO--(BUSINESS WIRE)--Biological Dynamics, Inc., a leader in exosome-isolation technology for early disease detection, announced a newly published study in Nature’s Communications Medicine ...

Organoids—tiny, lab-grown 3D clusters of cells—are a useful tool for studying organ development, disease, and drug responses. These miniature organs-in-a-dish are powerful, but they’re not perfect: ...

Pancreatic malignancies remain some of the most challenging cancers to treat. Experts anticipate over 52,000 pancreatic cancer-related deaths this year. Sadly, the five-year survival rate for ...